Adenocarcinoma of the lung with EGFR gene mutation and subsequent resistance mechanisms exploration: case report

The treatment of lung cancer has made paradigm-shift advancements in the past decade with the development of therapies directed at specific genetic alterations, such as epidermal growth factor receptor (EGFR). Here, we present a rare case of lung adenocarcinoma harboring EGFR activating mutation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Li, Wang, Qian Z, Wu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602471/
https://www.ncbi.nlm.nih.gov/pubmed/28979143
http://dx.doi.org/10.2147/OTT.S143501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602471/
https://www.ncbi.nlm.nih.gov/pubmed/28979143
http://dx.doi.org/10.2147/OTT.S143501

Ejemplares similares